Literature DB >> 24293811

Recent Advances in Development of DNA Vaccines Against Hepatitis C virus.

Sami Ullah1, Muhammad Ali A Shah, Nosheen Riaz.   

Abstract

Hepatitis C is one of the foremost challenging diseases all over the world. No vaccine has been developed, yet against Hepatitis C virus (HCV). This is partly due to the high mutation rate in the HCV genome, which generates new genotypes and sub genotypes. A mass of efforts have been devoted for the development of an efficient vaccine against HCV. DNA Vaccines, an emerging field of Vaccinology, grasp strong potential to be the most reliable and efficient mode of vaccination in the future. This technology is under investigation currently. Incredibly diverse approaches have been applied as an endeavor to develop a potent DNA vaccine against HCV. The HCV structural genes and the virus like particles have been attempted and so far the results are quite promising in the Lab animals. As there is no proper animal model for HCV infection except chimpanzees, it is very difficult to articulate whether these vaccines will also be pertinent in humans or not. This review will focus on different approaches being used for the development of DNA vaccines, the major tribulations in designing a DNA vaccine against HCV as well as the future prospects for the improvement of under trials DNA vaccines developed against HCV.

Entities:  

Keywords:  DNA vaccines; HCV; Virus like particles

Year:  2012        PMID: 24293811      PMCID: PMC3550791          DOI: 10.1007/s13337-012-0058-3

Source DB:  PubMed          Journal:  Indian J Virol        ISSN: 0970-2822


  41 in total

1.  Analysis of a successful immune response against hepatitis C virus.

Authors:  S Cooper; A L Erickson; E J Adams; J Kansopon; A J Weiner; D Y Chien; M Houghton; P Parham; C M Walker
Journal:  Immunity       Date:  1999-04       Impact factor: 31.745

Review 2.  Gene-based vaccines: recent technical and clinical advances.

Authors:  Jeffrey B Ulmer; Britta Wahren; Margaret A Liu
Journal:  Trends Mol Med       Date:  2006-04-18       Impact factor: 11.951

3.  Characterization of a prokaryotic SMC protein involved in chromosome partitioning.

Authors:  R A Britton; D C Lin; A D Grossman
Journal:  Genes Dev       Date:  1998-05-01       Impact factor: 11.361

Review 4.  DNA vaccines: an historical perspective and view to the future.

Authors:  Margaret A Liu
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

Review 5.  Studies of hepatitis C virus in chimpanzees and their importance for vaccine development.

Authors:  J Bukh; X Forns; S U Emerson; R H Purcell
Journal:  Intervirology       Date:  2001       Impact factor: 1.763

6.  [Construction and evaluation of hepatitis C virus (HCV) DNA vaccine containing E2-gAD fusion gene].

Authors:  Bo Wen; Yao Deng; Wen-Jie Tan; Xiao Ying; Ji-Ming Gao; Li Ruan
Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi       Date:  2010-02

7.  Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.

Authors:  Krystle A Lang; Jian Yan; Ruxandra Draghia-Akli; Amir Khan; David B Weiner
Journal:  Vaccine       Date:  2008-08-08       Impact factor: 3.641

8.  In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.

Authors:  Deepa K Krishnadas; Wen Li; Rakesh Kumar; Lorne J Tyrrell; Babita Agrawal
Journal:  Cell Immunol       Date:  2009-06-23       Impact factor: 4.868

9.  A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.

Authors:  S-H Wei; W Yin; Q-X An; Y-F Lei; X-B Hu; J Yang; X Lu; H Zhang; Z-K Xu
Journal:  Arch Virol       Date:  2008-04-18       Impact factor: 2.574

Review 10.  Variability of hepatitis C virus.

Authors:  P Simmonds
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

View more
  1 in total

1.  Expression of NS3/NS4A Proteins of Hepatitis C Virus in Huh7 Cells Following Engineering Its Eukaryotic Expression Vector.

Authors:  Mohammad Amin Behzadi; Abdolvahab Alborzi; Gholamreza Pouladfar; Mehdi Dianatpour; Mazyar Ziyaeyan
Journal:  Jundishapur J Microbiol       Date:  2015-11-26       Impact factor: 0.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.